Cargando...
HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease
In vitro and animal studies continue to elucidate the mechanisms of fibrosis and have led to advancements in treatment for idiopathic pulmonary fibrosis and cirrhosis, but the search for treatments for renal fibrosis has been more disappointing. Here, we will discuss homeodomain-interacting-protein...
Guardado en:
| Publicado en: | Front Physiol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4411988/ https://ncbi.nlm.nih.gov/pubmed/25972814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphys.2015.00132 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|